NewsEvents

Your Yourlocation: Home > Clinical observation of tiotropium bromide(136310-93-5) in the treatment of moderate and severe asthma

To observe the clinical efficacy of tiotropium bromide(136310-93-5) in the treatment of moderate and severe asthma and its effect on lung function. Studies have shown that regular inhaled corticosteroids and long-acting β receptor agonists in patients with moderate to severe asthma plus tiotropium bromide(136310-93-5) clinical efficacy significantly, and can effectively improve the patient's lung function. The article published on "Journal of Chinese Journal of Clinic".

One hundred and eighty-five patients with moderate and severe asthma were randomly divided into observation group and control group (n = 79). The control group received conventional inhaled budesonide / formoterol powder, and the observation group was given Tianto Bromide inhalation treatment, the control group with the same device inhaled placebo, compared the two groups after 1 year of clinical efficacy and changes in lung function.

(T = 3.015, P <0.05), the number of emergency drug use (t = 1.457, P <0.05) and FEV1, FEV1 (1) in the observation group after 1 year of treatment (FEV1%), forced vital capacity (FVC), peak expiratory flow velocity (PEF) and FEV1 / FVC were all significantly higher than those in the control group (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved